By KAI ICHINO/ Staff Writer
September 28, 2021 at 18:10 JST
Sotrovimab, a COVID-19 drug developed by GlaxoSmithKline K.K. (Provided by GlaxoSmithKline K.K.)
The health ministry granted fast-track approval for a neutralizing antibody on Sept. 27, making it the second COVID-19 treatment available in Japan for patients with mild symptoms. [Read More]
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
